Arbutus Biopharma Corp (ABUS) Operating margin 2016–2025
Arbutus Biopharma Corp (ABUS) operating margin by fiscal year — reported operating income divided by reported revenue.
-271.0%FY2025 · since FY2016: -32973.8% → -271.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -271.0% | +965.8 pp |
| FY2024 | -1236.7% | -806.2 pp |
| FY2023 | -430.5% | -262.8 pp |
| FY2022 | -167.8% | +501.4 pp |
| FY2021 | -669.1% | +167.0 pp |
| FY2020 | -836.1% | +1557.9 pp |
| FY2019 | -2394.0% | -883.8 pp |
| FY2018 | -1510.2% | -473.4 pp |
| FY2017 | -1036.7% | +31937.0 pp |
| FY2016 | -32973.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice